Mountain Crest Acquisition Corp. V announces termination of business combination with AUM Biosciences

Mountain Crest Acquisition Corp. V

AUM Biosciences delivered termination notice on June 8, 2023, ending the Business Combination Agreement.
Mountain Crest's board cancelled the special meeting of stockholders scheduled for June 23, 2023.
Transfer agent will not process any share redemption requests submitted by stockholders.
Original deal was signed October 19, 2022, amended multiple times, with combined company to trade as AUMB.
SPAC now must seek an alternative target or face potential liquidation.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Mountain Crest Acquisition Corp. V terminated Business Combination Agreement with AUM Biosciences Pte. Ltd. valued at Termination of Business Combination Agreement among Mountain Crest Acquisition Corp. V and AUM Biosc (effective 2023-06-08).

Action: termination
Agreement: merger
Counterparty: AUM Biosciences Pte. Ltd.
Value: Termination of Business Combination Agreement among Mountain Crest Acquisition Corp. V and AUM Biosc
Effective: 2023-06-08

Exact text from the filing

On June 8, 2023, Mountain Crest received a termination notice (the “Notice”) from AUM. The Notice terminated the Business Combination Agreement as of June 8, 2023.

View on SEC.gov

Browse all material agreements →

Mountain Crest Acquisition Corp. V filing history →

Source: SEC EDGAR

accession 0001829126-23-004262

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.